Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer

Sci Rep. 2017 Mar 16:7:44346. doi: 10.1038/srep44346.
No abstract available

Publication types

  • Published Erratum